World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
28455
World Ranking
12246
National Ranking
6270

Overview

Darrell M. Wilson is affiliated with Stanford University in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with significant contributions in endocrinology, diabetes, and metabolism. Other subfields of study include genetics, surgery, clinical psychology, and information systems.

Their work covers several main topics, including diabetes management and research, diabetes and associated disorders, pancreatic function and diabetes, hyperglycemia and glycemic control in critically ill and hospitalized patients, obesity, physical activity, diet, obesity and health practices, and immune cell function and interaction.

Wilson has published extensively in several venues, with notable frequent publications in Diabetes Care, The Journal of Clinical Endocrinology & Metabolism, Diabetes Technology & Therapeutics, UNC Libraries, and JAMA.

Their recent papers include the following:

  • Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial (2023), Diabetes Care
  • Association of Neonatal Hypoglycemia With Academic Performance in Mid-Childhood (2022), JAMA
  • IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes (2021), JCI Insight
  • Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR (2020), PLoS ONE
  • CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study (2023), Diabetes Care

Wilson frequently collaborates with several researchers, notably Carla J. Greenbaum, Jeffrey P. Krischer, Andrea K. Steck, Antoinette Moran, and Bruce A. Buckingham.

Best Publications

  • Continuous glucose monitoring and intensive treatment of type 1 diabetes.

    Tamborlane Wv;Beck Rw;Bode Bw

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • Pursuit of thinness and onset of eating disorder symptoms in a community sample of adolescent girls: A three‐year prospective analysis

    Joel D. Killen;C. Barr Taylor;Chris Hayward;Darrell M. Wilson

  • Weight concerns influence the development of eating disorders: A 4-year prospective study.

    J D Killen;C B Taylor;C Hayward;K F Haydel

  • Standardized percentile curves of body-mass index for children and adolescents.

    Lawrence D. Hammer;Helena C. Kraemer;Darrell M. Wilson;Philip L. Ritter

  • Educational video game for juvenile diabetes: results of a controlled trial

    S. J. Brown;D. A. Lieberman;B. A. Gemeny;Y. C. Fan

  • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Tihamer Orban;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Does Television Viewing Increase Obesity and Reduce Physical Activity? Cross-sectional and Longitudinal Analyses Among Adolescent Girls

    Thomas N. Robinson;LD Hammer;JD Killen;HC Kraemer

  • Dance and reducing television viewing to prevent weight gain in African-American girls: the Stanford GEMS pilot study.

    Thomas N Robinson;Joel D Killen;Helena C Kraemer;Darrell M Wilson

  • Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications.

    John A. Luetscher;Fredric B. Kraemer;Darrell M. Wilson;Herbert C. Schwartz

  • The effect of continuous glucose monitoring in well-controlled type 1 diabetes.

    Roy W Beck;Irl B Hirsch;Lori Laffel

  • Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit.

    Kupper A. Wintergerst;Bruce Buckingham;Laura Gandrud;Becky J. Wong

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

    Antoinette Moran;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes

    Wong Yu;Ning Jiang;Peter J.R. Ebert;Brian A. Kidd

  • Ethnicity and body dissatisfaction: Are Hispanic and Asian girls at increased risk for eating disorders?

    Thomas N. Robinson;Joel D. Killen;Iris F. Litt;Lawrence D. Hammer

  • Insulin-like growth factors I and II in evaluation of growth retardation

    Ron G. Rosenfeld;Darrell M. Wilson;Phillip D.K. Lee;Raymond L. Hintz

  • Normal ranges for immunochemiluminometric gonadotropin assays

    E.Kirk Neely;Raymond L. Hintz;Darrell M. Wilson;Peter A. Lee

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

Bruce A. Buckingham
Bruce A. Buckingham Stanford University
Ron G. Rosenfeld
Ron G. Rosenfeld Oregon Health & Science University
Raymond L. Hintz
Raymond L. Hintz Stanford University
Roy W. Beck
Roy W. Beck University of South Florida
David M. Maahs
David M. Maahs Stanford University
Joel D. Killen
Joel D. Killen Stanford University
Desmond A. Schatz
Desmond A. Schatz University of Florida
Jay S. Skyler
Jay S. Skyler University of Miami
William V. Tamborlane
William V. Tamborlane Yale University
Antoinette Moran
Antoinette Moran University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine but want flexible education options, numerous online healthcare degrees can help you advance or change your career. For those interested in healthcare management, the top online mha programs that are cahme accredited offer a reputable path for building leadership skills and understanding hospital administration.

Nursing professionals can pursue rn to bsn programs designed to help RNs earn their bachelor’s degree without additional clinical requirements—ideal for busy working nurses.

Those seeking advanced practice can opt for the quickest dnp program to obtain a Doctor of Nursing Practice (DNP) in a shorter time frame, helping fast-track your career advancement. Many professionals are also choosing flexible, reputable dnp programs online, which make it easier to balance study, work, and life.

These alternative and advanced online degrees provide diverse career pathways for those passionate about making an impact in healthcare—from administration to direct patient care.

Best Scientists Citing Darrell M. Wilson

Trending Scientists